BWX Technologies
BWXT
$143.83
+1.13%
BWX Technologies, Inc. is a specialty manufacturer and service provider of nuclear components operating through two segments: Government Operations, which produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, and Commercial Operations, which designs and manufactures nuclear steam generators, heat exchangers, pressure vessels, reactor components, and spent-fuel storage containers. The company occupies a uniquely entrenched competitive position as the sole large-scale naval reactor manufacturer in North America, giving it monopoly-like defense contracts that generate the majority of revenue, complemented by a growing commercial nuclear franchise tied to the global nuclear energy renaissance. The current investor narrative is sharply divided: bulls point to a 50% backlog increase in 2025, expanding commercial nuclear capacity through acquisitions, and a valuation that screens cheaper than nuclear peers, while bears focus on execution risk, margin compression, and a stock that has fallen dramatically from its highs despite fundamentally improving revenue. Recent headlines capture this tension, with Motley Fool calling BWXT "the cheapest nuclear stock" while Benzinga noted the stock slid on acquisition news as the market weighed near-term execution risks over long-term strategic expansion.…
BWXT
BWX Technologies
$143.83
Related headlines
Investment Opinion: Should I buy BWXT Today?
The synthesized recommendation is a Hold. The core thesis is that BWXT's fundamental business is performing well with 18% revenue growth and a monopoly in naval nuclear, but the stock is in a severe downtrend with margin compression and premium valuation, creating a balanced risk/reward. The analyst consensus is buy with an average target of $215.51, implying 49.8% upside, but the stock trades below the lowest analyst target of $150, indicating the market is pricing in risks not reflected in analyst models.
Supporting evidence includes: revenue growth of 18.0% YoY in Q2 2026, a forward PE of 27.5x (still a premium to the sector but lower than trailing 48.0x), ROE of 26.75%, and free cash flow of $316.8M. However, gross margin has declined to 22.44% from 25.05% a year ago, and the debt-to-equity ratio of 1.635 is high. The implied upside to the average analyst target is substantial, but the wide target range ($150-$290) signals high uncertainty.
The biggest risks are continued margin erosion, acquisition integration challenges, and a breakdown below the 52-week low of $131.86. The rating would upgrade to Buy if gross margin stabilizes above 23% and the stock holds above $150, or downgrade to Sell if revenue growth decelerates below 10% or margins fall below 20%. Relative to its history, the stock is undervalued on a PS basis (4.95 vs. 19.8 in Q2 2026), but relative to peers, it remains overvalued on PE and EV/EBITDA. Thus, it is fairly valued to slightly overvalued on a peer basis but undervalued on a historical basis.
Sign up to view all
BWXT 12-Month Price Forecast
The forward view is neutral with medium confidence. BWXT's fundamental growth story is intact, but the stock is in a severe downtrend and faces margin pressure. The wide analyst target range and the fact that the stock trades below the lowest target suggest the market is pricing in significant risks. An upgrade to bullish would require evidence of margin stabilization and a technical reversal above $160, while a downgrade to bearish would occur if margins fall further or revenue growth slows below 10%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on BWX Technologies's 12-month outlook, with a consensus price target around $215.51 and implied upside of +49.8% versus the current price.
Average Target
$215.51
0 analysts
Implied Upside
+49.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$150 - $290
Analyst target range
BWX Technologies is covered by 16 analysts, and the consensus recommendation is "buy" with a recommendation mean of 1.61 (where 1.0 is a strong buy and 5.0 is a strong sell), indicating a moderately bullish stance. The average target price is $215.51, which implies a staggering +49.8% upside from the current price of $143.83, a spread that is unusually wide and suggests significant disagreement or a market that has overshot to the downside relative to analyst expectations. The consensus EPS estimate for the forward period is $7.71 (range of $7.39 to $8.48), and estimated revenue averages $5.43 billion, which would represent continued growth from the current run-rate. Despite the bullish consensus, the stock has fallen far below even the lowest analyst target, creating a notable disconnect that could signal either a buying opportunity or that analysts are lagging the market's reassessment.
The target price range is extraordinarily wide, from a low of $150.00 to a high of $290.00, a spread of $140 or 93% of the low target, which signals high uncertainty about the company's future. The high target of $290 assumes successful integration of acquisitions, accelerating commercial nuclear revenue, and multiple expansion back toward historical highs, while the low target of $150 (still 4.3% above the current price) prices in margin compression, execution missteps, or a broader de-rating of nuclear sector valuations. Recent institutional ratings show a mixed but slightly improving picture: Wells Fargo upgraded from Underweight to Equal Weight on August 27, 2026, Deutsche Bank upgraded from Hold to Buy on May 15, 2026, and Seaport Global upgraded from Neutral to Buy on June 18, 2026, while BNP Paribas maintained Neutral and Truist maintained Hold. The pattern of upgrades from major banks suggests that while the stock has been punished, some analysts see the selloff as overdone, but the wide target range and the fact that the stock trades below the lowest target indicate that the market is pricing in risks that analysts have not fully incorporated into their models.
Bulls vs Bears: BWXT Investment Factors
The bear case currently has stronger evidence due to the severe price downtrend, margin compression, and premium valuation. However, the bull case is supported by accelerating revenue growth, a monopoly position, and a significant analyst target upside. The most critical tension is whether the margin decline is temporary (due to acquisition integration) or structural; if margins stabilize, the stock could re-rate sharply, but continued erosion would justify further downside.
Bullish
- Revenue growth accelerating: Q2 2026 revenue grew 18.0% YoY to $901.6M, following 26.2% growth in Q1 2026 and 28.9% in Q3 2025. This consistent double-digit expansion demonstrates robust demand for naval nuclear reactors and commercial nuclear components.
- Monopoly in naval nuclear: BWXT is the sole large-scale manufacturer of naval nuclear reactors in North America, operating in a monopoly-like position for U.S. Naval Nuclear Propulsion Program contracts. Government Operations contributed $577.9M (64.1% of Q2 2026 revenue), providing a stable, high-barrier backlog.
- Analyst upside substantial: The consensus analyst target price is $215.51, implying 49.8% upside from the current $143.83. With 16 analysts covering and a recommendation mean of 1.61 (buy), the Street sees significant undervaluation.
- Valuation below historical: The PS ratio has compressed to 4.95 from 19.8 in Q2 2026 and 17.9 in Q4 2025, while the PB ratio fell to 12.84 from 14.64 in Q1 2026. This suggests the stock is trading at a deep discount to its recent valuation band.
Bearish
- Severe price downtrend: The stock is down 26.5% over 1 year and 37.3% over 6 months, sitting just 4.9% above its 52-week low of $131.86. It has underperformed SPY by 42.5% over 1 year, indicating a structural bear market.
- Margin compression evident: Gross margin declined to 22.44% in Q2 2026 from 25.05% in Q2 2025, and operating margin fell to 9.97% from 13.41% a year earlier. EBITDA margin also dropped to 13.45% from 16.38% in Q1 2026.
- Elevated valuation multiples: The trailing PE is 48.0x and forward PE is 27.5x, both at a premium to the Aerospace & Defense sector average of 20-25x. EV/EBITDA of 31.4x is more than double the sector average of 12-15x.
- High leverage and low FCF yield: Debt-to-equity is 1.635, and the FCF yield is only ~2.0% based on $316.8M FCF and $15.8B market cap. The company relies on debt for acquisitions, introducing refinancing risk.
BWXT Technical Analysis
BWX Technologies is in a pronounced and sustained downtrend, with the current price of $143.83 sitting just 4.9% above its 52-week low of $131.86 and a staggering 40.5% below its 52-week high of $241.82, placing it in the bottom 5% of its 52-week range. The 1-year price change of -26.47% and 6-month decline of -37.35% confirm that this is not a temporary pullback but a structural bear market for the stock, with the max drawdown reaching -43.65% from peak to trough. At this positioning, the stock is neither a momentum play nor a comfortable value entry; it is a falling knife that requires either a confirmed technical reversal or a fundamental catalyst to stabilize.
Short-term momentum remains decisively negative and is diverging bearishly from an already weak long-term trend. The 1-month change of -8.22% and 3-month change of -22.67% show that selling pressure has intensified rather than abated, with the stock losing ground at an accelerating pace over the past quarter. Relative strength metrics paint an even starker picture: BWXT has underperformed SPY by -10.34% over 1 month, -25.80% over 3 months, and a remarkable -42.47% over 1 year, indicating that capital is actively rotating out of this name even as the broader market (SPY +16.0% 1-year) rallies. The most recent session showed a modest +1.13% bounce on volume of 786,612 shares, but this is insufficient to signal a trend change.
Key technical levels are now clearly defined: support rests at the 52-week low of $131.86, which if breached would open the door to a new leg down and likely trigger further institutional selling, while resistance sits at the 52-week high of $241.82, a level that would require a 68% rally to reclaim. The stock's beta of 0.738 indicates it is roughly 26% less volatile than the broader market, which is somewhat surprising given the magnitude of its decline; this low beta suggests the selloff is driven by company-specific and sector-specific factors rather than broad market beta, and it implies that position sizing should account for the fact that this is an idiosyncratic risk story. A breakout above even intermediate resistance (around the $160-$170 zone where the stock consolidated in August-September) would be the first technical signal that the downtrend is exhausting, while a breakdown below $131.86 would confirm the bear thesis and likely accelerate losses.
Beta
0.74
0.74x market volatility
Max Drawdown
-43.6%
Largest decline past year
52-Week Range
$132-$242
Price range past year
Annual Return
-26.5%
Cumulative gain past year
| Period | BWXT Return | S&P 500 |
|---|---|---|
| 1m | -8.2% | +1.9% |
| 3m | -22.7% | +3.9% |
| 6m | -37.3% | +12.1% |
| 1y | -26.5% | +19.2% |
| ytd | -20.9% | +14.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BWXT Fundamental Analysis
BWX Technologies' revenue trajectory remains solidly positive even as its stock price collapses, creating a notable disconnect between operating performance and market sentiment. The most recent quarter (Q2 2026, ended June 30) delivered revenue of $901.6 million, representing 18.01% year-over-year growth versus $764.0 million in Q2 2025, and this follows a clear multi-quarter acceleration: Q1 2026 revenue of $861.1 million (+26.2% YoY vs. $682.3 million), Q4 2025 revenue of $885.8 million (+18.7% YoY vs. $746.3 million), and Q3 2025 revenue of $866.3 million (+28.9% YoY vs. $672.0 million). The revenue segment breakdown shows Government Operations contributing $577.9 million (64.1% of the $901.6 million total) and Commercial Operations contributing $283.6 million (31.5%), with the government segment remaining the anchor while commercial operations expand. This consistent double-digit top-line growth, driven by naval nuclear propulsion demand and commercial nuclear capacity expansion, suggests the fundamental business is performing well even as the equity is being repriced.
Profitability remains intact but is showing signs of margin pressure that may be contributing to the stock's derating. Net income in Q2 2026 was $89.0 million with a net margin of 9.87%, down from $91.2 million and a 10.59% net margin in Q1 2026, and gross margin compressed to 22.44% in Q2 2026 from 22.99% in Q1 2026 and 25.05% in Q2 2025. The trailing gross margin of 22.87% and operating margin of 10.11% are respectable for a specialty defense manufacturer but reflect a downward trend from the 24-25% gross margins seen in 2024 and early 2025. EBITDA of $121.2 million in Q2 2026 (13.45% EBITDA margin) declined from $141.1 million (16.38% margin) in Q1 2026, and the operating income ratio fell to 9.97% from 13.41% in Q2 2025, indicating that cost pressures, possibly from acquisition integration and capacity expansion, are weighing on profitability. The company remains solidly profitable with a 10.31% net margin and 26.75% ROE, but the margin trajectory bears watching.
Balance sheet and cash flow metrics reveal a company that is adequately capitalized but carrying meaningful leverage. The debt-to-equity ratio of 1.635 is elevated for an industrial, and the current ratio of 2.32 provides reasonable short-term liquidity, but the cash flow picture is mixed: trailing free cash flow is $316.8 million, Q2 2026 FCF was $115.0 million (up from $50.1 million in Q1 2026), and operating cash flow of $156.4 million in Q2 2026 was strong. However, the company paid $24.7 million in dividends in Q2 2026 and has been actively investing in capex ($41.4 million in Q2 2026) and acquisitions, with the Q2 2025 period showing $441.4 million in acquisition spending. The FCF yield of approximately 2.0% (based on $316.8 million FCF and $15.8 billion market cap) is modest, and the ROE of 26.75% is flattered by the high leverage. The company generates enough cash to fund operations and dividends but relies on debt markets for major strategic initiatives, which introduces refinancing risk in a higher-rate environment.
Quarterly Revenue
$901625000.0B
2026-06
Revenue YoY Growth
+18.0%
YoY Comparison
Gross Margin
22.4%
Latest Quarter
Free Cash Flow
$316762000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BWXT Overvalued?
Because BWX Technologies is profitable with positive net income of $89.0 million in Q2 2026 and trailing EPS of $0.0208 (which appears distorted by one-time items or a data anomaly), the PE ratio is the appropriate primary metric, though the trailing PE of 48.01x and forward PE of 27.50x tell very different stories. The massive gap between trailing and forward PE implies the market expects earnings to more than double, which is consistent with analyst EPS estimates of $7.71 for the forward period versus the trailing figure. However, the trailing PE of 48x is rich for an industrial with 10% net margins, and the PEG ratio of 2.84 suggests the stock is expensive relative to its growth rate. The PS ratio of 4.95 and EV/EBITDA of 31.44 are also elevated, though the EV/Sales of 4.11 is more moderate.
Compared to the broader Aerospace & Defense sector, BWXT trades at a significant premium on most metrics. The sector average PE is typically in the 20-25x range, meaning BWXT's trailing PE of 48x represents a roughly 92-140% premium, and even the forward PE of 27.5x is a 10-38% premium to sector norms. The PS ratio of 4.95 is also above the sector median of approximately 2-3x, and the EV/EBITDA of 31.4x is more than double the sector average of 12-15x. This premium is partially justified by BWXT's unique monopoly position in naval nuclear reactors and its exposure to the secular nuclear energy growth theme, but the magnitude of the premium leaves little room for execution missteps, which may explain why the stock has sold off so aggressively despite strong revenue growth.
On a historical basis, BWXT's current valuation is near the low end of its own recent range, which is the most compelling part of the bull case. The PE ratio has compressed from 50.2x in Q2 2026 to 48.0x currently, but more importantly, the PS ratio of 4.95 is well below the 19.8x seen in Q2 2026 and the 17.9x in Q4 2025, reflecting the massive stock price decline. The PB ratio of 12.84 is also down from 13.38x in Q2 2026 and 14.64x in Q1 2026. This compression suggests that either the market is pricing in a significant deterioration in fundamentals that has not yet appeared in the financials, or the stock is oversold relative to its historical valuation band and represents a value opportunity for investors who believe the growth trajectory is intact.
PE
48.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~52x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
31.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The debt-to-equity ratio of 1.635 is elevated for an industrial, and the current ratio of 2.32 provides adequate but not exceptional liquidity. Gross margin has compressed from 25.05% in Q2 2025 to 22.44% in Q2 2026, and operating margin fell from 13.41% to 9.97% over the same period, indicating cost pressures from acquisition integration and capacity expansion. Additionally, revenue is heavily concentrated in Government Operations (64.1% of Q2 2026 revenue), making the company dependent on U.S. defense budgets and naval contracts.
Market and competitive risks are pronounced. The stock trades at a trailing PE of 48.0x and EV/EBITDA of 31.4x, well above sector averages, leaving little room for execution missteps. With a beta of 0.738, the stock is less volatile than the market, but it has underperformed SPY by 42.5% over 1 year, suggesting idiosyncratic issues. The nuclear sector is subject to regulatory changes and competition from alternative energy sources, and recent acquisition news triggered a sell-off, highlighting market skepticism about near-term execution.
The worst-case scenario involves a breakdown below the 52-week low of $131.86, which could accelerate institutional selling. If margin compression continues and acquisition integration falters, the stock could fall to the analyst low target of $150 (though this is above current price) or lower; a more realistic downside target is the 52-week low of $131.86, representing a 8.3% decline from the current $143.83. In a severe bear case, if the stock revisits its max drawdown of -43.65% from the 52-week high, it could fall to around $136, but a more dire scenario might see it drop to $120, implying a 16.6% loss from current levels.
FAQ
The key risks include: 1) Financial risk: high debt-to-equity of 1.635 and low FCF yield of ~2.0%, with margin compression (gross margin down to 22.44% from 25.05%). 2) Competitive/operational risk: dependence on government contracts (64.1% of revenue) and execution risk on acquisitions. 3) Macro risk: defense budget cuts or regulatory changes could impact naval nuclear programs. 4) Valuation risk: premium multiples could compress further if growth slows. The most severe risk is a breakdown below the 52-week low of $131.86, which could trigger further selling.
The 12-month forecast has three scenarios: Bull case (25% probability) targets $215-$290, assuming margin recovery and successful acquisition integration. Base case (50% probability) targets $150-$200, with modest margin stabilization and steady growth. Bear case (25% probability) targets $120-$150, if margins continue to compress and the stock breaks below $131.86. The base case is most likely, with the key assumption that gross margin stabilizes around 22-23% and revenue grows 10-15%. Analyst consensus average target is $215.51, but the stock currently trades below the lowest target of $150, indicating market skepticism.
BWXT's valuation is nuanced. On a trailing PE of 48.0x and EV/EBITDA of 31.4x, it is overvalued relative to the Aerospace & Defense sector average of 20-25x PE and 12-15x EV/EBITDA. However, the forward PE of 27.5x suggests the market expects earnings to more than double, and the PS ratio of 4.95 is well below its historical levels of 19.8 in Q2 2026 and 17.9 in Q4 2025. This implies the stock is undervalued relative to its own history but still carries a premium to peers. The market is pricing in significant growth and margin recovery, leaving little room for error.
BWXT presents a mixed risk/reward profile. The stock trades at $143.83, with a consensus analyst target of $215.51 implying 49.8% upside, but it is down 26.5% over the past year and sits just 4.9% above its 52-week low. The fundamental business is growing revenue at 18% YoY, but margins are compressing, and the valuation remains at a premium to peers on a trailing PE of 48.0x. For long-term investors with a high risk tolerance, the monopoly position in naval nuclear and the nuclear energy tailwind could justify a position, but near-term execution risks and the downtrend suggest waiting for signs of stabilization. It is not a good buy for short-term traders or conservative investors.
BWXT is more suitable for long-term investment given its monopoly position in naval nuclear, exposure to the secular nuclear energy growth theme, and a dividend yield of 0.58%. The stock's beta of 0.738 indicates lower volatility than the market, but it has experienced a max drawdown of -43.65%, so it is not low-risk. Short-term trading is risky due to the strong downtrend and lack of technical support until $131.86. A suggested minimum holding period is 2-3 years to allow for margin recovery and acquisition integration. The company's earnings visibility is high due to long-term defense contracts, but near-term execution risks persist.